18F-FLT uptake kinetics in head and neck squamous cell carcinoma: a PET imaging study.

PURPOSE To analyze the kinetics of 3(')-deoxy-3(')-[F-18]-fluorothymidine (18F-FLT) uptake by head and neck squamous cell carcinomas and involved nodes imaged using positron emission tomography (PET). METHODS Two- and three-tissue compartment models were fitted to 12 tumor time-activity-curves (TACs) obtained for 6 structures (tumors or involved nodes) imaged in ten dynamic PET studies of 1 h duration, carried out for five patients. The ability of the models to describe the data was assessed using a runs test, the Akaike information criterion (AIC) and leave-one-out cross-validation. To generate parametric maps the models were also fitted to TACs of individual voxels. Correlations between maps of different parameters were characterized using Pearson'sr coefficient; in particular the phosphorylation rate-constants k3-2tiss and k5 of the two- and three-tissue models were studied alongside the flux parameters KFLT- 2tiss and KFLT of these models, and standardized uptake values (SUV). A methodology based on expectation-maximization clustering and the Bayesian information criterion ("EM-BIC clustering") was used to distil the information from noisy parametric images. RESULTS Fits of two-tissue models 2C3K and 2C4K and three-tissue models 3C5K and 3C6K comprising three, four, five, and six rate-constants, respectively, pass the runs test for 4, 8, 10, and 11 of 12 tumor TACs. The three-tissue models have lower AIC and cross-validation scores for nine of the 12 tumors. Overall the 3C6K model has the lowest AIC and cross-validation scores and its fitted parameter values are of the same orders of magnitude as literature estimates. Maps of KFLT and KFLT- 2tiss are strongly correlated (r = 0.85) and also correlate closely with SUV maps (r = 0.72 for KFLT- 2tiss, 0.64 for KFLT). Phosphorylation rate-constant maps are moderately correlated with flux maps (r = 0.48 for k3-2tiss vs KFLT- 2tiss and r = 0.68 for k5 vs KFLT); however, neither phosphorylation rate-constant correlates significantly with SUV. EM-BIC clustering reduces the parametric maps to a small number of levels--on average 5.8, 3.5, 3.4, and 1.4 for KFLT- 2tiss, KFLT, k3-2tiss, and k5. This large simplification is potentially useful for radiotherapy dose-painting, but demonstrates the high noise in some maps. Statistical simulations show that voxel level noise degrades TACs generated from the 3C6K model sufficiently that the average AIC score, parameter bias, and total uncertainty of 2C4K model fits are similar to those of 3C6K fits, whereas at the whole tumor level the scores are lower for 3C6K fits. CONCLUSIONS For the patients studied here, whole tumor FLT uptake time-courses are represented better overall by a three-tissue than by a two-tissue model. EM-BIC clustering simplifies noisy parametric maps, providing the best description of the underlying information they contain and is potentially useful for radiotherapy dose-painting. However, the clustering highlights the large degree of noise present in maps of the phosphorylation rate-constantsk5 and k3-2tiss, which are conceptually tightly linked to cellular proliferation. Methods must be found to make these maps more robust-either by constraining other model parameters or modifying dynamic imaging protocols.

[1]  Sung-Cheng Huang,et al.  Derivation of a Compartmental Model for Quantifying 64Cu-DOTA-RGD Kinetics in Tumor-Bearing Mice , 2009, Journal of Nuclear Medicine.

[2]  R. Jain,et al.  Microvascular permeability of albumin, vascular surface area, and vascular volume measured in human adenocarcinoma LS174T using dorsal chamber in SCID mice. , 1993, Microvascular research.

[3]  Vincent Gregoire,et al.  Molecular imaging-based dose painting: a novel paradigm for radiation therapy prescription. , 2011, Seminars in radiation oncology.

[4]  G. Watkins,et al.  Kinetic Analysis of 3′-Deoxy-3′-18F-Fluorothymidine (18F-FLT) in Head and Neck Cancer Patients Before and Early After Initiation of Chemoradiation Therapy , 2009, Journal of Nuclear Medicine.

[5]  T. Cloughesy,et al.  18 F-fluorothymidine kinetics of malignant brain tumors , 2007 .

[6]  K. Jingu,et al.  Focal dose escalation using FDG-PET-guided intensity-modulated radiation therapy boost for postoperative local recurrent rectal cancer: a planning study with comparison of DVH and NTCP , 2010, BMC Cancer.

[7]  C Cobelli,et al.  Kinetic modeling of [(18)F]FDG in skeletal muscle by PET: a four-compartment five-rate-constant model. , 2001, American journal of physiology. Endocrinology and metabolism.

[8]  Ewert Bengtsson,et al.  Noise correlation in PET, CT, SPECT and PET/CT data evaluated using autocorrelation function: a phantom study on data, reconstructed using FBP and OSEM , 2005, BMC Medical Imaging.

[9]  Mark Muzi,et al.  Kinetic modeling of 3'-deoxy-3'-fluorothymidine in somatic tumors: mathematical studies. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[10]  Hubert Vesselle,et al.  FLT: measuring tumor cell proliferation in vivo with positron emission tomography and 3'-deoxy-3'-[18F]fluorothymidine. , 2007, Seminars in nuclear medicine.

[11]  D Eidelberg,et al.  Quantitative brain FDG/PET studies using dynamic aortic imaging. , 1994, Physics in medicine and biology.

[12]  Eric O. Aboagye,et al.  Imaging early changes in proliferation at 1 week post chemotherapy: a pilot study in breast cancer patients with 3′-deoxy-3′-[18F]fluorothymidine positron emission tomography , 2007, European Journal of Nuclear Medicine and Molecular Imaging.

[13]  D. Feng,et al.  Noninvasive Quantification of the Cerebral Metabolic Rate for Glucose Using Positron Emission Tomography, 18F-Fluoro-2-Deoxyglucose, the Patlak Method, and an Image-Derived Input Function , 1998, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[14]  C. Cobelli,et al.  Parameter and structural identifiability concepts and ambiguities: a critical review and analysis. , 1980, The American journal of physiology.

[15]  Søren M Bentzen,et al.  Theragnostic imaging for radiation oncology: dose-painting by numbers. , 2005, The Lancet. Oncology.

[16]  M A Konerding,et al.  3D microvascular architecture of pre-cancerous lesions and invasive carcinomas of the colon , 2001, British Journal of Cancer.

[17]  R. Boellaard,et al.  Reproducibility of quantitative 18F-3′-deoxy-3′-fluorothymidine measurements using positron emission tomography , 2009, European Journal of Nuclear Medicine and Molecular Imaging.

[18]  D. Feng,et al.  Models for computer simulation studies of input functions for tracer kinetic modeling with positron emission tomography. , 1993, International journal of bio-medical computing.

[19]  S. Yao,et al.  The Role of Human Nucleoside Transporters in Uptake of 3′-Deoxy-3′-fluorothymidine , 2008, Molecular Pharmacology.

[20]  Kewei Chen,et al.  An input function estimation method for FDG-PET human brain studies. , 2007, Nuclear medicine and biology.

[21]  W. Oyen,et al.  18F-FLT PET Does Not Discriminate Between Reactive and Metastatic Lymph Nodes in Primary Head and Neck Cancer Patients , 2007, Journal of Nuclear Medicine.

[22]  John L. Humm,et al.  Evaluation of a compartmental model for estimating tumor hypoxia via FMISO dynamic PET imaging , 2008, Physics in medicine and biology.

[23]  Sung-Cheng Huang,et al.  18F-fluorothymidine kinetics of malignant brain tumors , 2007, European Journal of Nuclear Medicine and Molecular Imaging.

[24]  D. Visvikis,et al.  Comparison of methodologies for the in vivo assessment of 18FLT utilisation in colorectal cancer , 2004, European Journal of Nuclear Medicine and Molecular Imaging.

[25]  R. Boellaard,et al.  Reproducibility of quantitative 18 F-3 ′-deoxy-3 ′-fluorothymidine measurements using positron emission tomography , 2009 .

[26]  S S Gambhir,et al.  A fast nonlinear method for parametric imaging of myocardial perfusion by dynamic (13)N-ammonia PET. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[27]  Rakesh K Jain,et al.  Lymphatic Metastasis in the Absence of Functional Intratumor Lymphatics , 2002, Science.

[28]  Mark Muzi,et al.  Kinetic analysis of 3'-deoxy-3'-18F-fluorothymidine in patients with gliomas. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[29]  P. Marsden,et al.  Correlation between Ki-67 immunohistochemistry and 18F-fluorothymidine uptake in patients with cancer: A systematic review and meta-analysis. , 2012, European journal of cancer.

[30]  R. Jain,et al.  Absence of functional lymphatics within a murine sarcoma: a molecular and functional evaluation. , 2000, Cancer research.

[31]  L. Wiens,et al.  Validation of FLT uptake as a measure of thymidine kinase-1 activity in A549 carcinoma cells. , 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[32]  Adrian E. Raftery,et al.  How Many Clusters? Which Clustering Method? Answers Via Model-Based Cluster Analysis , 1998, Comput. J..

[33]  Adrian C. Shieh,et al.  Biomechanical Forces Shape the Tumor Microenvironment , 2011, Annals of Biomedical Engineering.

[34]  Otto Muzik,et al.  A simplified analysis of [18F]3′-deoxy-3′-fluorothymidine metabolism and retention , 2005, European Journal of Nuclear Medicine and Molecular Imaging.

[35]  N. Laird,et al.  Meta-analysis in clinical trials revisited. , 2015, Contemporary clinical trials.

[36]  Stefan Eberl,et al.  Evaluation of two population-based input functions for quantitative neurological FDG PET studies , 1997, European Journal of Nuclear Medicine.

[37]  J. Sherley,et al.  Regulation of human thymidine kinase during the cell cycle. , 1988, The Journal of biological chemistry.

[38]  Fang-Xiang Wu,et al.  Genetic weighted k-means algorithm for clustering large-scale gene expression data , 2008, BMC Bioinformatics.

[39]  David R. Anderson,et al.  Multimodel Inference , 2004 .

[40]  Paul Marsden,et al.  Estimation of input functions from dynamic [18F]FLT PET studies of the head and neck with correction for partial volume effects , 2013, EJNMMI Research.

[41]  G A Ojemann,et al.  Glucose metabolism in human malignant gliomas measured quantitatively with PET, 1-[C-11]glucose and FDG: analysis of the FDG lumped constant. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[42]  Rakesh K. Jain,et al.  Transport of molecules across tumor vasculature , 2004, Cancer and Metastasis Reviews.

[43]  Jeih-San Liow,et al.  Image-Derived Input Function for Human Brain Using High Resolution PET Imaging with [11C](R)-rolipram and [11C]PBR28 , 2011, PloS one.

[44]  Johan Bussink,et al.  PET–CT for radiotherapy treatment planning and response monitoring in solid tumors , 2011, Nature Reviews Clinical Oncology.

[45]  Michael Horn,et al.  Tumour size measurement in a mouse model using high resolution MRI , 2012, BMC Medical Imaging.

[46]  Torsten Mattfeldt,et al.  Imaging proliferation in lung tumors with PET: 18F-FLT versus 18F-FDG. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[47]  J. Schwartz,et al.  The role of nucleoside/nucleotide transport and metabolism in the uptake and retention of 3'-fluoro-3'-deoxythymidine in human B-lymphoblast cells. , 2011, Nuclear medicine and biology.

[48]  C C Ling,et al.  Towards multidimensional radiotherapy (MD-CRT): biological imaging and biological conformality. , 2000, International journal of radiation oncology, biology, physics.

[49]  D Feng,et al.  A computer simulation study on the effects of input function measurement noise in tracer kinetic modeling with positron emission tomography (PET). , 1993, Computers in biology and medicine.

[50]  H. Vesselle,et al.  Tumor 3′-Deoxy-3′-18F-Fluorothymidine (18F-FLT) Uptake by PET Correlates with Thymidine Kinase 1 Expression: Static and Kinetic Analysis of 18F-FLT PET Studies in Lung Tumors , 2011, The Journal of Nuclear Medicine.

[51]  M. Bal,et al.  Dose painting by contours versus dose painting by numbers for stage II/III lung cancer: practical implications of using a broad or sharp brush. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[52]  Tania B. Huedo-Medina,et al.  Assessing heterogeneity in meta-analysis: Q statistic or I2 index? , 2006, Psychological methods.

[53]  G. Glatting,et al.  Evaluation of pyrimidine metabolising enzymes and in vitro uptake of 3'-[18F]fluoro-3'-deoxythymidine ([18F]FLT) in pancreatic cancer cell lines , 2002, European Journal of Nuclear Medicine and Molecular Imaging.

[54]  Mark Muzi,et al.  In vivo validation of 3'deoxy-3'-[(18)F]fluorothymidine ([(18)F]FLT) as a proliferation imaging tracer in humans: correlation of [(18)F]FLT uptake by positron emission tomography with Ki-67 immunohistochemistry and flow cytometry in human lung tumors. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[55]  J. Rodgers,et al.  Thirteen ways to look at the correlation coefficient , 1988 .

[56]  K. Krohn,et al.  Different Modes of Transport for 3H-Thymidine, 3H-FLT, and 3H-FMAU in Proliferating and Nonproliferating Human Tumor Cells , 2010, The Journal of Nuclear Medicine.

[57]  R. Dennis Cook,et al.  Cross-Validation of Regression Models , 1984 .

[58]  I. Buvat,et al.  Partial-Volume Effect in PET Tumor Imaging* , 2007, Journal of Nuclear Medicine.

[59]  K. Herholz,et al.  Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group. , 1999, European journal of cancer.

[60]  Kristian Pietras,et al.  High interstitial fluid pressure — an obstacle in cancer therapy , 2004, Nature Reviews Cancer.

[61]  S. Thompson,et al.  Quantifying heterogeneity in a meta‐analysis , 2002, Statistics in medicine.

[62]  A. Shinomiya,et al.  Evaluation of 3′-deoxy-3′-[18F]-fluorothymidine (18F-FLT) kinetics correlated with thymidine kinase-1 expression and cell proliferation in newly diagnosed gliomas , 2012, European Journal of Nuclear Medicine and Molecular Imaging.

[63]  Eric P. Visser,et al.  A Curve-Fitting Approach to Estimate the Arterial Plasma Input Function for the Assessment of Glucose Metabolic Rate and Response to Treatment , 2009, Journal of Nuclear Medicine.

[64]  Y. Nishiyama,et al.  Correlation of 18F-FLT and 18F-FDG uptake on PET with Ki-67 immunohistochemistry in non-small cell lung cancer , 2007, European Journal of Nuclear Medicine and Molecular Imaging.

[65]  Sung-Cheng Huang,et al.  Evaluation of an Input Function Model that Incorporates the Injection Schedule in FDG-PET Studies , 2006, 2006 IEEE Nuclear Science Symposium Conference Record.

[66]  R K Jain,et al.  Transport of molecules in the tumor interstitium: a review. , 1987, Cancer research.

[67]  H. Vesselle,et al.  A SepPak unit for batch processing serial blood plasma samples for PET , 2007 .

[68]  D. Mankoff,et al.  18F-Fluorothymidine radiation dosimetry in human PET imaging studies. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[69]  S. Huang,et al.  The effects of measurement errors in the plasma radioactivity curve on parameter estimation in positron emission tomography. , 1991, Physics in medicine and biology.

[70]  Gunilla Borgefors Theory and applications of image analysis II : selected papers from the 9th Scandinavian Conference on Image Analysis , 1995 .

[71]  Mark Muzi,et al.  Kinetic analysis of 3'-deoxy-3'-fluorothymidine PET studies: validation studies in patients with lung cancer. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[72]  W. G. Cochran The $\chi^2$ Test of Goodness of Fit , 1952 .